[Results of controlled trial of metiazinic acid (16091 RP) in rheumatic pelvi-spondylitis, coxarthrosis and psoriatic rheumatism].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006621:Hip Joint; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D010640:Phenothiazines
Résultat d'un essai contrôlé de l'acide métiazinique (16091 RP) dans la pelvispondylite rhumatismale, la coxarthrose et le rhumatisme psoriasique.